Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Sanofi - American Depositary Shares (NQ:SNY)

40.67 -0.56 (-1.36%)

Delayed Quote Updated: 4:00 PM EDT, Oct 1, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	6,681,832
Open	41.85
Bid (Size)	40.60 (200)
Ask (Size)	40.88 (100)
Prev. Close	41.23
Today's Range	40.63 - 41.88
52wk Range	40.40 - 52.68
Shares Outstanding	1,250,690,553
Dividend Yield	5.96%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Sanofi, Regeneron Expand DUPIXENT Alliance in Deal Worth Up to €8 Billion ↗

Today 10:03 EDT

Regeneron and Sanofi (NASDAQ:SNY) announced an expanded collaboration focused on developing next-generation medicines for type 2 inflammatory diseases, extending an alliance that has produced the...

Via MarketBeat

Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies

Today 1:00 EDT

From Regeneron Pharmaceuticals, Inc.

Via GlobeNewswire

Performance

YTD	-15.7%	-15.7%
1 Month	-8.3%	-8.3%
3 Month	-2.3%	-2.3%
6 Month	-14.8%	-14.8%
1 Year	-13.8%	-13.8%

More News

Is Regeneron Stock a Bargain Below $800? ↗

September 22, 2026

Via The Motley Fool

Sanofi Reviews Pipeline, Broadens Deal Hunt as It Rebuilds Research Engine ↗

September 22, 2026

Via MarketBeat

Sanofi-ADR (NASDAQ:SNY): A Dividend Quality Candidate with Solid Profitability ↗

August 27, 2026

Via Chartmill

Sanofi (NASDAQ:SNY) Screens as Undervalued Value Stock with Solid Profitability ↗

August 07, 2026

Via Chartmill

Sanofi-ADR (NASDAQ:SNY) Offers a High Dividend Yield With Strong Underlying Quality ↗

July 16, 2026

Via Chartmill

Sanofi Eyes €25B Dupixent Future, Expands M&A Hunt Ahead of Patent Loss ↗

September 20, 2026

Via MarketBeat

A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach

September 08, 2026

Via Investor Brand Network

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Gains Editorial Spotlight Following FDA Clearance for Lucid-MS Phase 2 Trial

September 08, 2026

Via Investor Brand Network

SANOFI-ADR (NASDAQ:SNY): A Decent Value Stock With Strong Fundamentals and an Undervalued Profile ↗

July 13, 2026

Via Chartmill

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Gains Editorial Spotlight Following FDA Clearance for Lucid-MS Phase 2 Trial

September 08, 2026

Via Investor Brand Network

MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Gains Editorial Spotlight Following FDA Clearance for Lucid-MS Phase 2 Trial

September 08, 2026

Via Investor Brand Network

A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach

September 08, 2026

From BioMedWire

Via GlobeNewswire

Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now? ↗

September 04, 2026

Via The Motley Fool

Sanofi Boasts a Dividend Yield of 5.4%, Trades Below 9x Earnings, and Just Got an FDA Win. Are Income Investors Missing a Rare Opportunity? ↗

August 26, 2026

Via The Motley Fool

Sanofi Q2 Earnings Call Highlights ↗

July 30, 2026

Via MarketBeat

The Smartest Dividend Stock to Buy With $1,000 Right Now (Spoiler: It Yields 5.6%.) ↗

July 28, 2026

Via The Motley Fool

Next-Generation Diabetes Therapies Are Reshaping Healthcare and Creating MultiBillion-Dollar Revenue Opportunities

July 21, 2026

Via FinancialNewsMedia

3 High-Yield Dividend Stocks to Buy and Hold ↗

July 17, 2026

Via The Motley Fool

2 Fast-Growing Pharmaceutical Stocks to Buy Now ↗

July 08, 2026

Via The Motley Fool

Bargain Hunters: These 3 High-Yielding Stocks Recently Hit New 52-Week Lows ↗

June 30, 2026

Via The Motley Fool

MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials

June 22, 2026

Via Investor Brand Network

Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis

June 22, 2026

Via Investor Brand Network

Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis

June 22, 2026

From BioMedWire

Via GlobeNewswire

Frequently Asked Questions

Is Sanofi - American Depositary Shares publicly traded?

Yes, Sanofi - American Depositary Shares is publicly traded.

What exchange does Sanofi - American Depositary Shares trade on?

Sanofi - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Sanofi - American Depositary Shares?

The ticker symbol for Sanofi - American Depositary Shares is SNY on the Nasdaq Stock Market

What is the current price of Sanofi - American Depositary Shares?

The current price of Sanofi - American Depositary Shares is 40.67

When was Sanofi - American Depositary Shares last traded?

The last trade of Sanofi - American Depositary Shares was at 10/01/26 04:00 PM ET

What is the market capitalization of Sanofi - American Depositary Shares?

The market capitalization of Sanofi - American Depositary Shares is 50.87B

How many shares of Sanofi - American Depositary Shares are outstanding?

Sanofi - American Depositary Shares has 51B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.